Merged thread
Minnesota's leading epidemiologist gets Long Covid
Osterholm learns firsthand what long COVID does
Epidemiologist is wary about future variants.
By RACHEL HUTTON
rachel.hutton@startribune.com
Michael Osterholm, Minnesota's longtime infectious disease specialist and Biden White House adviser, has been a voice of caution through the pandemic — and one of the most careful among us in protecting himself from COVID.
This past March, as many people had dispensed with nasal swabs and masks, Osterholm celebrated his 70th birthday by hosting a few (tested) guests for dinner and attending a small, uncrowded music show (wearing an N-95 mask). And yet, he got his first SARS CoV-2 infection.
We checked in with Osterholm about his experience with long COVID, his perspective on where we are in our pandemic journey, and why he still sleeps with one eye open.
This interview has been edited for length and clarity.
Q: After three years of educating people about COVID, you finally got it.
A: I was one of three people who got infected the same night. We don't know exactly where we got it. I think the only time all three of us didn't have a fitted N-95 mask on was just a short elevator ride in my building.
[...]
Q: Can you give us a preview of your forthcoming book?
A: It's about the lessons we should have learned from this pandemic. Over the next several months, we're about to see the public health system in this country systematically dismantled.
I've never seen anything like this in my 48 years in the business — the amount of clawback that has happened with resources and funds.
We're going to see major layoffs in public health agencies all across the country at federal, state and local levels. We're going to see research scaled back substantially on infectious diseases.
Q: What do those kind of cuts mean?
A: If you add it all up, and then you realize the lack of trust that exists now in public health, I think we're less prepared for the future than we were in 2019 and 2020. And it doesn't have to be that way. We have to continue to sustain efforts to get better vaccines.
Seasonal flu still kills a lot of people. What if we had the holy grail vaccine that actually had broad protection, durability, and could be administered around the world without a minus-30-degree cold chain? Wouldn't that be something? Now more than ever we should be really hunkering down and looking at that as a strategic goal.
[...]